Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Fluoxetine | Prozac | 4.5. Interactions with other medicinal products | Interaction with Benzodiazepines, Antipsychotics, Drug that is tightly bound to protein (e.g., Coumadin, Digitoxin) and Olanzapine. | Mar,2023 |
| Talazoparib Tosylate | Talzenna | 4.5. Interactions with other medicinal products | Interactions with P-gp inducer, rifampin, and rifampin | Mar,2023 |
| Fentanyl | Abstral | 4.5. Interactions with other medicinal products | Interaction with gabapentinoids (gabapentin and pregabalin) | Aug, 2024 |
| Omeprazole | Losec Mups | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Acute tubulointerstitial nephritis , Tubulointerstitial nephritis | Jan,2023 |
| Cefuroxime | Zinnat | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Hypersensitivity reactions, Severe cutaneous adverse reactions. Drug Reaction with Eosinophilia and Systemic Symptoms , Kounis syndrome | Jan,2023 |
| Erythromycin | Erythrodar Forte | 4.8 Undesirable effects | Rash | Aug, 2024 |